跳至主要内容
临床试验/EUCTR2005-003496-20-GB
EUCTR2005-003496-20-GB进行中(未招募)1 期

The effect of pre-operative Octreotide LAR treatment on surgical cure rates of subjects with Acromegaly, and post-operative responsiveness to somatostatin analogue treatment in patients not cured surgically. - Pre-operative Octreotide LAR for Acromegaly

Oxford Radcliffe Hospitals NHS trust0 个研究点目标入组 0 人开始时间: 2006年10月16日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Acromegaly undergoing pituitary surgery in Oxford
  • Macroadenoma (pituitary tumour >1cm in size on MRI)
  • Not taking concomittant somatostatin analogue therapy
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Microadenoma
  • Previous surgery or radiotherapy
  • Liver dysfunction
  • Renal Failure (creat >200UMOL/L)
  • Known Cardiac conduction disease
  • History of Pancreatitis
  • Breast Feeding

研究者

发起方
Oxford Radcliffe Hospitals NHS trust

相似试验

The effect of pre-operative Octreotide LAR treatment... | 临床试验